Alkyl Amines seeks approval for director re-designations and commission
Alkyl Amines Chemicals Limited seeks shareholder approval via postal ballot for the re-designation of Yogesh M. Kothari as Executive Chairman and Kirat M. Patel and Suneet Y. Kothari as Joint Managing Directors. The ballot also includes the appointment of Rakesh Goyal as Executive Director (Operations) and authorization for non-executive director commissions. E-voting runs from August 21 to September 19, 2026.

*this image is generated using AI for illustrative purposes only.
Alkyl Amines Chemicals has initiated a postal ballot process to seek shareholder approval for significant changes in its board structure and director remuneration policies. The company aims to formalize leadership transitions by re-designating its current top executives into new roles, ensuring continuity in management while aligning with regulatory requirements for directors over the age of seventy.
The postal ballot notice, issued pursuant to Section 110 read with Section 108 of the Companies Act, 2013 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, outlines five special resolutions for member consideration. These resolutions focus on the re-designation of existing directors and the appointment of new executive roles, effective from October 1, 2026, and April 1, 2027.
Key Resolutions for Shareholder Approval
The Board of Directors, at its meeting held on August 4, 2026, recommended the following special resolutions:
- Re-designation of Yogesh M. Kothari: Approval for his re-designation as Executive Chairman from October 1, 2026, until March 31, 2030. This change is required as he has crossed seventy years of age, necessitating a special resolution under the Companies Act.
- Re-designation of Kirat M. Patel: Approval for his elevation from Executive Director to Joint Managing Director, effective October 1, 2026, until December 31, 2029. Similar to Mr. Kothari, this requires shareholder approval due to his age exceeding seventy years.
- Re-designation of Suneet Y. Kothari: Approval for his elevation from Executive Director to Joint Managing Director, effective October 1, 2026, until December 31, 2029. His aggregate remuneration with Mr. Yogesh M. Kothari exceeds 5% of net profits, triggering the need for a special resolution under SEBI Listing Regulations.
- Appointment of Rakesh Goyal: Approval for his re-designation and appointment as Executive Director (Operations) for five years, from April 1, 2027, to March 31, 2032.
- Director Commission Authorization: Authorization for payment of commission to Non-Executive Directors at a rate not exceeding 1% of net profits for five years, starting April 1, 2027.
Voting Schedule and Process
Shareholders holding equity shares as on the cut-off date of August 14, 2026, are eligible to vote via remote e-voting through National Securities Depository Limited (NSDL). The voting window opens on August 21, 2026, at 9:00 am and closes on September 19, 2026, at 5:00 pm. Results will be declared on or before September 22, 2026.
| Event | Date | Time |
|---|---|---|
| Cut-off date | August 14, 2026 | - |
| Voting commencement | August 21, 2026 | 9:00 am |
| Voting end | September 19, 2026 | 5:00 pm |
| Result declaration | On or before September 22, 2026 | - |
The company emphasized that the notice is being sent only through electronic mode to members with registered email addresses. Those without registered emails must follow specific procedures outlined in the notice to receive credentials for e-voting. The scrutinizer appointed for the process is Mr. Prashant S. Mehta of P. Mehta & Associates.
Historical Stock Returns for Alkyl Amines Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.99% | -0.80% | +4.06% | +23.03% | -8.86% | -55.29% |
How might the transition of Yogesh M. Kothari to Executive Chairman and the elevation of Kirat and Suneet Kothari to Joint Managing Directors impact Alkyl Amines' strategic direction and operational stability?
What are the potential implications for shareholder returns given the authorization of up to 1% of net profits as commission for Non-Executive Directors starting in 2027?
Could the age-related regulatory requirements for directors over seventy influence future succession planning or board composition strategies at Alkyl Amines Chemicals?


































